You searched for "fusion"

1806 results found

Twenty-five years in retina

In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...

Implementing technology to improve global eye health

Technological innovation is providing new solutions to transform global eye health [1–5]. In particular, research towards the development of artificial intelligence (AI) tools in ophthalmology has gained pace in recent years. However, there has been little research relating to its...

Newer generation IOL platforms designed for high-quality visual performance after cataract surgery

Expanding intraocular lens (IOL) capabilities provide broadening options, ranging from next-generation monofocal IOLs for basic cataract surgery, to specialised premium IOLs for lens-based presbyopia correction and astigmatism correction at the time of cataract surgery. Rod McNeil considers several newer alternative...

Sight Scotland urge new First Minister to "open his eyes to inclusivity and accessibility challenges for vision impaired"

Sight Scotland and its sister charity Sight Scotland Veterans are calling on the new Frist Minister, Humza Yousaf MSP, to improve inclusivity and accessibility for the vision impaired.

OKKO Health announce collaboration with the University of Plymouth to measure vision in extreme environments including space

OKKO Health, a leader in innovative eye health technology, is excited to announce its collaboration with the University of Plymouth. This groundbreaking project will test eye health and track early disease detection in extreme environments, beginning with the depths of a cave and soon to monitor astronauts’ vision in the vastness of space.

The Worshipful Company of Spectacle Makers rewards early career research

The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...

Young visionaries win global competition by re-designing the Glasses of the Future

The International Agency for the Prevention of Blindness (IAPB) celebrated UNICEF World Children’s Day by announcing the winners of ‘Glasses of the Future’, a global competition that invited children across the world to design the next generation of glasses. Lama...

Scottish Braille Press makes accessibility statement with new 60k braille printer investment

The Scottish Braille Press, which is part of Sight Scotland, has announced a significant investment in a state-of-the-art braille printer to bolster its support for individuals with vision impairments across the UK. This new printer, imported from Norway at a...

New support pathway for children with sight loss launches to address vital need for consistency of care

A new eye care support pathway to help children and young people with a vision impairment get the support they need, has been launched today by partners from across the sight loss sector. This sets out the care and services...

Biotech Healthcare unveils Optiflex XTENSE Comfort Plus at ESCRS 2025 (Copenhagen), marking a new era in Full Visual Range EDOF IOLs

Biotech Healthcare proudly introduced its newest advancement in intraocular lens technology — Optiflex XTENSE Comfort Plus, a Full Visual Range EDOF IOL, during the ESCRS 2025 meeting in Copenhagen. The product launch at Biotech’s booth drew widespread attention and appreciation...

“She’s the Lewis Capaldi of the art world”: the young visually impaired artist transforming creativity

Hannah Evans (17) from Linlithgow, has been creating art since she was three years old and has three group exhibitions and three large solo shows under her belt. She is also partially sighted, autistic, and has specific learning and communication disabilities.

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...